Kowani wrote:Xmara wrote:This is great, but 34 million isn’t that many when you consider just how many people live in poorer countries.
Unless that’s all they can supply.
noting that i am not privy to internal supply chain discussions, i suspect it's a mixture of supply limitations and preexisting contractsNorth Washington Republic wrote:
Honestly, I think giving vaccines directly to countries that need them is more effective than liberalization of patens. This ensures that the vaccines are made correctly, and they are ready to use.
no, the patents would be a game-changer
do you think the rest of the world doesn't have quality control???
I know this may sound bigoted but the quality controls of developed countries are better than those of developing countries. You know me, I’m not one of those assholes that say “let poor people in other countries die.” Hell, we should be sending vaccines to countries that need them because the MAGAs don’t want it. We should especially focus shipping on the one-dose J&J vaccine because poorer people in developing countries may have trouble making it to their 2nd jab. If we focus on sending already made vaccines to countries, we don’t have to worry about quality.